Subscribe
Subscribe

ElmediX wants to stop coronavirus by heating patients in a controlled manner

Mechelen, Belgium, 24 March 2020 - The coronavirus has brought the whole world to a standstill. The Belgian company ElmediX wants to contain the virus with intensive heat treatments for corona patients. Controlled heating to 41.5 °C for three hours can inactivate the virus and activate the patient's immune system. ElmediX has launched a call to researchers and doctors and makes the technology available in the fight against the coronavirus.

Montis Biosciences launched with €8.4 million seed financing and a novel approach to immuno-oncology

Leuven, Belgium, Feb 20th 2020 - Montis Biosciences announces its launch with €8,4 million in seed financing from an international investor syndicate to investigate interactions between perivascular macrophages and tumor vasculature. The company’s mission is to exploit these cellular interactions with therapeutics to drive and sustain immune reactions against solid tumors.

PharmaFluidics announces product range extension for its µPACᵀᴹ chromatography chips to serve new biopharma markets

Ghent, Belgium, February 10, 2020 - PharmaFluidics NV, an innovative player in the field of analytical chromatography, announces a product range extension into capillary flow rate liquid chromatography (capillary LC).  PharmaFluidics initiates commercial supplies of its new µPAC™ capLC column, bringing unprecedented sensitivity, reproducibility and robustness to a new range of customers worldwide, including the biopharmaceutical industry. PharmaFluidics’ unique high-resolution µPAC™ micro-Chip technology enables separation and detection of individual compounds in complex biological samples such as biopsies, proteome digests, culture media or biopharmaceutical actives, with unmatched precision.

V-Bio Ventures invests in RootWave in a EUR 6.5 M Series A financing to develop and market electrical weed killing solutions

Ghent (Belgium), 20th of January 2020 - Today V-Bio Ventures announces its investment in RootWave, a pioneer in electrical weed killing solutions. RootWave secured ca. EUR 6.5m in a Series A investment round led by V-Bio Ventures (Belgium) and Rabo Food & Agri Innovation Fund (Netherlands), and joined by impact fund Pymwymic (Netherlands) and existing shareholders including Yield Lab Ireland. The proceeds will enable RootWave to expand commercialisation of its RootWave Pro, a professional hand-weeder for spot weeding and treating invasive species, integrate its technology into automated agricultural weeders, and conduct further research into novel electricity-based weed killing applications.

V-Bio Ventures invests in Augustine Therapeutics, a VIB and KU Leuven spin-off to fight neuromuscular diseases

Ghent, Belgium, December 16 2019 – Today V-Bio Ventures announces its investment in Augustine Therapeutics, a new venture developing innovative therapeutics for patients suffering from Charcot-Marie-Tooth disease. A spin-off of VIB and KU Leuven, Augustine raises a seed-round of 4.2 million euro with V-Bio Ventures, PMV, Advent France Biotechnology, Gemma Frisius Fund and VIB.

Caelus Health and Nestlé Health Science sign exclusive global development & option agreement on Caelus’ microbiome-based food supplements

PRESS RELEASE Amsterdam/Beerse, November 25, 2019 – Caelus Health, which develops food supplements and pharmaceutical products for the prevention, early treatment and management of cardio-metabolic diseases, is entering into a strategic collaboration with Nestlé Health Science (NHSc). The aim is to further develop and ultimately commercialize food supplements based on specific microbiota for the purpose of early intervention and nutritional management of diabetes and certain liver disorders.

Pulsify Medical to develop a wearable heart monitor patch

Pulsify Medical, a joint imec and KU Leuven spin-off, has closed a seed funding round of €2.6 million. The investment, led by imec.xpand and KU Leuven, will be used to develop a wearable ultrasound patch to non-invasively monitor organs like the heart.

Ovizio Imaging Systems announces iLine F and BioConnect supply agreements with Celgene Corporation

Brussels, Belgium 22/10/2019 – Ovizio Imaging Systems, a company providing an innovative microscopic imaging technology to the bioprocessing market, today announces the execution of supply agreements with Celgene Corporation for the automation of certain engineered T cell manufacturing processes.

Prof. Matthias Mann joins PharmaFluidics Advisory Board

Ghent, Belgium – October 22, 2019 – PharmaFluidics NV, an innovative player in the field of proteomics with the unique high-resolution µPACTM micro-Chip chromatography products, is pleased to welcome Prof. Dr. Matthias Mann as member of its Advisory Board.

Pulsify Medical, a joint imec and KU Leuven spin-off, closes first-round funding, led by imec.xpand

Pulsify Medical will develop wearable ultrasound patches for non-invasive, real time monitoring of physiological parameters inside the body.

Gilead and Galapagos enter into transformative research and development collaboration

Confo Therapeutics and DyNAbind announce drug discovery collaboration to identify novel GPCR-modulating compounds

Stellar year for Belgian biotech

Belgium has once again strengthened its position as Europe's biotech leader. Today, Belgian biotech companies comprise 23 percent of the total market value of all public European biotech companies. Compared to the end of April 2018, the value of Belgian biotech companies increased by 12.5 percent from 24 to 27 billion euros. A few Belgian biotech giants such as Galapagos, argenx and UCB, are responsible for this growth. This according to figures announced by KBC Securities during the "State of the Union" event of the Flemish biotech sector federation flanders.bio and VIB on the eve of the large "knowledge for growth" congress in Ghent.

Holographic imaging technology shines a light on cells

Have you ever considered how scientists are able to count transparent cells in a see-through solution? Traditional methods involve dyes, microscopes, time and effort. Now there’s a new technology on the market: Ovizio Imaging Systems has developed a technical solution to this longstanding problem. Using an imaging technique called digital holographic microscopy, Ovizio’s devices perform cell counts by reconstructing 3D images using light. This new type of imaging provides quantitative information about cells, including their number, morphology and viability, all without a drop of dye!

From scientist to entrepreneur: how a Belgian chromatography company came to be